Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tyme Technologies (TYME)

Tyme Technologies (TYME)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 146,180
  • Shares Outstanding, K 122,840
  • Annual Sales, $ 0 K
  • Annual Income, $ -22,000 K
  • 60-Month Beta 0.97
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1500 +2.61%
on 07/13/20
1.5750 -25.08%
on 06/23/20
-0.1700 (-12.59%)
since 06/12/20
3-Month
1.0878 +8.48%
on 04/22/20
1.7800 -33.71%
on 05/20/20
-0.1300 (-9.92%)
since 04/14/20
52-Week
0.8601 +37.19%
on 03/18/20
2.0400 -42.16%
on 01/17/20
-0.0700 (-5.60%)
since 07/12/19

Most Recent Stories

More News
TYME Provides Business Update and Announces Preliminary First Quarter Fiscal 2021 Financial and Operating Results

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs(TM)), announced preliminary financial and operating results for its first fiscal...

TYME : 1.1800 (-0.84%)
Tyme Technologies Announces Virtual 2020 Annual Meeting of Stockholders

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs(TM)), announced that TYME will hold its 2020 Annual Meeting of Stockholders...

TYME : 1.1800 (-0.84%)
TYME-18 Demonstrates Anti-Cancer Effect in New Preclinical Data Presented at AACR 2020

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs(TM)), announced new preclinical findings that describe the unique anti-cancer...

TYME : 1.1800 (-0.84%)
TYME Presents New Preclinical Data Supporting SM-88 Mechanism of Action at AACR 2020

--- Builds on confirmed tumor responses achieved in human clinical studies across 15 different cancer types

TYME : 1.1800 (-0.84%)
TYME Announces Abstracts Selected for Publication at the 2020 American Society of Clinical Oncology Annual Meeting

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs(TM)), announced that two abstracts will be published at the American Society...

TYME : 1.1800 (-0.84%)
Tyme Technologies to Present at BIO Digital from June 8-12, 2020

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs(TM)), announced that management will present a corporate overview for 2020...

TYME : 1.1800 (-0.84%)
TYME Announces Fourth Quarter and Fiscal Year 2020 Financial and Operating Results

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs(TM)), announced preliminary financial and operating results for its fourth...

TYME : 1.1800 (-0.84%)
Tyme Technologies to Present at Jefferies Virtual Healthcare Conference on June 3, 2020

Tyme Technologies, Inc. (NASDAQ:TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs(TM)), announced that leadership will participate at the Jefferies Virtual Healthcare...

TYME : 1.1800 (-0.84%)
Health Economic Research Study Presented at ISPOR, and Published in the Journal Value in Health, Demonstrates Reduction in Total Cost of Care with Increased Use of New Medicines for Treatment of Patients with Pancreatic Cancer

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism based therapies (CMBTs(TM)), announced the results of a health economic outcomes study demonstrating...

TYME : 1.1800 (-0.84%)
TYME Announces Abstracts Selected for Presentation at the American Association for Cancer Research, AACR 2020

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs(TM)), announced that two posters will be presented at the American Association...

TYME : 1.1800 (-0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade TYME with:

Business Summary

Tyme Technologies, Inc. is a pharmaceutical company. The company is focused on creating medicines which specialize in the body's immune system to treat diseases. Tyme Technologies, Inc. is headquartered in New York.

See More

Key Turning Points

2nd Resistance Point 1.2700
1st Resistance Point 1.2300
Last Price 1.1800
1st Support Level 1.1500
2nd Support Level 1.1100

See More

52-Week High 2.0400
Fibonacci 61.8% 1.5893
Fibonacci 50% 1.4500
Fibonacci 38.2% 1.3108
Last Price 1.1800
52-Week Low 0.8601

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar